Inactive Instrument

News International Stem Cell Corp OTC Bulletin Board

Equities

ISCO

US4603781026

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Mar. 28	International Stem Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	International Stem Cell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

International Stem Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
International Stem Cell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
International Stem Cell Corporation and Dr. Andrey Semechkin Agrees to Extend (Until September 15, 2024) the Maturity Date of the Loan	23-09-18	CI
Bayer says Parkinson's stem cell therapy improves symptoms in initial trial	23-08-28	RE
International Stem Cell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Bayer claims early lead in Parkinson's stem cell therapy	23-06-28	RE
INTERNATIONAL STEM CELL CORP : Submission of Matters to a Vote of Security Holders (form 8-K)	23-06-21	AQ
International Stem Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
INTERNATIONAL STEM CELL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-30	AQ
International Stem Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
International Stem Cell Corporation Auditor Raises 'Going Concern' Doubt	23-03-29	CI
INTERNATIONAL STEM CELL CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	23-03-16	AQ
INTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-14	AQ
International Stem Cell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
INTERNATIONAL STEM CELL CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22-09-16	AQ
INTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-12	AQ
International Stem Cell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
INTERNATIONAL STEM CELL CORP : Submission of Matters to a Vote of Security Holders (form 8-K)	22-06-14	AQ
INTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-05-13	AQ
International Stem Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News International Stem Cell Corp OTC Bulletin Board

Equities

ISCO

US4603781026

Summary

Filters